Literature DB >> 29530482

Recent computational studies of membrane interaction and disruption of human islet amyloid polypeptide: Monomers, oligomers and protofibrils.

Xuewei Dong1, Qin Qiao2, Zhenyu Qian3, Guanghong Wei4.   

Abstract

The amyloid deposits of human islet amyloid polypeptide (hIAPP) are found in type 2 diabetes patients. hIAPP monomer is intrinsically disordered in solution, whereas it can form amyloid fibrils both in vivo and in vitro. Extensive evidence suggests that hIAPP causes the disruption of cellular membrane, and further induces cytotoxicity and the death of islet β-cells in pancreas. The presence of membrane also accelerates the hIAPP fibril formation. hIAPP oligomers and protofibrils in the early stage of aggregation were reported to be the most cytotoxic, disrupting the membrane integrity and giving rise to the pathological process. The detailed molecular mechanisms of hIAPP-membrane interactions and membrane disruption are complex and remain mostly unknown. Here in this review, we focus on recent computational studies that investigated the interactions of full length and fragmentary hIAPP monomers, oligomers and protofibrils with anionic, zwitterionic and mixed anionic-zwitterionic lipid bilayers. We mainly discuss the binding orientation of monomers at membrane surface, the conformational ensemble and the oligomerization of hIAPP inside membranes, the effect of lipid composition on hIAPP oligomers/protofibrils-membrane interactions, and the hIAPP-induced membrane perturbation. This review provides mechanistic insights into the interactions between hIAPP and lipid bilayers with different lipid composition at an atomistic level, which is helpful to understand the hIAPP cytotoxicity mediated by membrane. This article is part of a Special Issue entitled: Protein Aggregation and Misfolding at the Cell Membrane Interface edited by Ayyalusamy Ramamoorthy.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid aggregates; Conformational ensemble; Human islet amyloid polypeptide; Membrane disruption; Molecular dynamics simulations; Type 2 diabetes

Year:  2018        PMID: 29530482     DOI: 10.1016/j.bbamem.2018.03.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  7 in total

1.  Computer simulations of protein-membrane systems.

Authors:  Jennifer Loschwitz; Olujide O Olubiyi; Jochen S Hub; Birgit Strodel; Chetan S Poojari
Journal:  Prog Mol Biol Transl Sci       Date:  2020-02-26       Impact factor: 3.622

2.  Metastable intermediate during hIAPP aggregation catalyzed by membranes as detected with 2D IR spectroscopy.

Authors:  Sidney S Dicke; Michał Maj; Caitlyn R Fields; Martin T Zanni
Journal:  RSC Chem Biol       Date:  2022-06-13

3.  The Effect of Cholesterol on Membrane-Bound Islet Amyloid Polypeptide.

Authors:  Mikkel Christensen; Nils A Berglund; Birgit Schiøtt
Journal:  Front Mol Biosci       Date:  2021-04-22

4.  Correction: Shedding light on the structural properties of lipid bilayers using molecular dynamics simulation: a review study.

Authors:  Sajad Moradi; Amin Nowroozi; Mohsen Shahlaei
Journal:  RSC Adv       Date:  2019-03-12       Impact factor: 3.361

Review 5.  How Melittin Inserts into Cell Membrane: Conformational Changes, Inter-Peptide Cooperation, and Disturbance on the Membrane.

Authors:  Jiajia Hong; Xuemei Lu; Zhixiong Deng; Shufeng Xiao; Bing Yuan; Kai Yang
Journal:  Molecules       Date:  2019-05-07       Impact factor: 4.411

6.  Structural Dissection of the First Events Following Membrane Binding of the Islet Amyloid Polypeptide.

Authors:  Lucie Khemtemourian; Hebah Fatafta; Benoit Davion; Sophie Lecomte; Sabine Castano; Birgit Strodel
Journal:  Front Mol Biosci       Date:  2022-03-15

Review 7.  Shedding light on the structural properties of lipid bilayers using molecular dynamics simulation: a review study.

Authors:  Sajad Moradi; Amin Nowroozi; Mohsen Shahlaei
Journal:  RSC Adv       Date:  2019-02-06       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.